Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1955 2
1962 1
1963 4
1964 5
1966 1
1967 2
1968 2
1971 2
1972 2
1973 1
1974 1
1975 1
1976 1
1977 3
1978 2
1979 1
1980 2
1981 4
1982 4
1983 3
1984 9
1985 14
1986 6
1987 9
1988 8
1989 13
1990 10
1991 9
1992 8
1993 18
1994 22
1995 21
1996 14
1997 18
1998 25
1999 33
2000 28
2001 34
2002 35
2003 43
2004 20
2005 25
2006 17
2007 12
2008 20
2009 16
2010 9
2011 15
2012 24
2013 19
2014 17
2015 15
2016 31
2017 37
2018 37
2019 23
2020 21
2021 13
2022 18
2023 25
2024 11
2025 21

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

817 results

Results by year

Filters applied: . Clear all
Page 1
[CAR-T therapy for malignant lymphoma].
Shimoyama T. Shimoyama T. Rinsho Ketsueki. 2023;64(11):1447-1455. doi: 10.11406/rinketsu.64.1447. Rinsho Ketsueki. 2023. PMID: 38072433 Review. Japanese.
Trastuzumab Deruxtecan in Anti-Human Epidermal Growth Factor Receptor 2 Treatment-Naive Patients With Human Epidermal Growth Factor Receptor 2-Low Gastric or Gastroesophageal Junction Adenocarcinoma: Exploratory Cohort Results in a Phase II Trial.
Yamaguchi K, Bang YJ, Iwasa S, Sugimoto N, Ryu MH, Sakai D, Chung HC, Kawakami H, Yabusaki H, Lee J, Shimoyama T, Lee KW, Saito K, Kawaguchi Y, Kamio T, Kojima A, Sugihara M, Shitara K. Yamaguchi K, et al. Among authors: shimoyama t. J Clin Oncol. 2023 Feb 1;41(4):816-825. doi: 10.1200/JCO.22.00575. Epub 2022 Nov 15. J Clin Oncol. 2023. PMID: 36379002 Free PMC article. Clinical Trial.
[Polatuzumab vedotin, bendamustine, and rituximab in patients with relapsed/refractory diffuse large B-cell lymphoma, including the outcome as a bridging treatment to CAR-T cell therapy or allogeneic hematopoietic stem cell transplant].
Morita Y, Yagi Y, Kanemasa Y, Sasaki Y, Ishimine K, Hayashi Y, Mino M, Ohigashi A, Tamura T, Nakamura S, Okuya T, Shimizuguchi T, Shingai N, Toya T, Shimizu H, Najima Y, Kobayashi T, Haraguchi K, Doki N, Okuyama Y, Ohashi K, Shimoyama T. Morita Y, et al. Among authors: shimoyama t. Rinsho Ketsueki. 2023;64(7):586-595. doi: 10.11406/rinketsu.64.586. Rinsho Ketsueki. 2023. PMID: 37544717 Japanese.
[Bevacizumab (Avastin)].
Shimoyama T. Shimoyama T. Gan To Kagaku Ryoho. 2009 Mar;36(3):523-30. Gan To Kagaku Ryoho. 2009. PMID: 19295286 Japanese.
[Rebamipide].
Shimoyama T, Fukuda S, Liu Q, Sugawara K. Shimoyama T, et al. Nihon Rinsho. 2002 Feb;60 Suppl 2:698-703. Nihon Rinsho. 2002. PMID: 11979874 Review. Japanese. No abstract available.
Peripheral ameloblastic fibroma.
Ide F, Shimoyama T, Horie N. Ide F, et al. Among authors: shimoyama t. Oral Oncol. 2000 May;36(3):308. doi: 10.1016/s1368-8375(99)00089-5. Oral Oncol. 2000. PMID: 11202978 Review. No abstract available.
Early failure is still a poor prognostic factor in patients with relapsed or refractory large B-cell lymphoma in the era of CAR T-cell therapy.
Yagi Y, Kanemasa Y, Sasaki Y, Goto S, Yamamura Y, Masuda Y, Fujita K, Ishimine K, Hayashi Y, Mino M, Ohigashi A, Morita Y, Tamura T, Nakamura S, Okuya T, Matsuda S, Shimizuguchi T, Shingai N, Toya T, Shimizu H, Najima Y, Kobayashi T, Haraguchi K, Doki N, Okuyama Y, Shimoyama T. Yagi Y, et al. Among authors: shimoyama t. J Clin Exp Hematop. 2024;64(2):107-118. doi: 10.3960/jslrt.24009. J Clin Exp Hematop. 2024. PMID: 38925972 Free PMC article.
Nutrition and diet in inflammatory bowel disease.
Yamamoto T, Shimoyama T. Yamamoto T, et al. Among authors: shimoyama t. Curr Opin Gastroenterol. 2023 Mar 1;39(2):110-114. doi: 10.1097/MOG.0000000000000905. Epub 2023 Jan 3. Curr Opin Gastroenterol. 2023. PMID: 36821459 Review.
817 results